Influencing factors of community-acquired pneumonia in patients with chronic obstructive pulmonary disease
Objective:To analyze influencing factors of community-acquired pneumonia in patients with chronic obstructive pulmonary disease(COPD).Methods:A cross-sectional study was conducted on 186 patients with COPD admitted to this hospital from January 2021 to February 2023.The clinical data of these patients were collected.The inflammatory markers and hemoglobin(Hb)levels were detected.The BODE scoring system was used to evaluate the survival status of these COPD patients.According to whether community-acquired pneumonia occurred,they were divided into occurrence group and non-occurrence group.Logistic regression was used to analyze the influencing factors of community-acquired pneumonia in these COPD patients.Results:Among the 186 patients with COPD,63 cases of community-acquired pneumonia occurred,with an incidence of 33.87%(63/186).There were no significant differences in gender,body mass index,smoking,combined hypoproteinemia,combined hypertension,BODE score,recent application of antibiotics,recent application of β2 receptor agonists,long-term bed rest,C-reactive protein(CRP)level and Hb level between the two groups(P>0.05).The proportions of the patients with age≥70 years old,combined diabetes mellitus,mechanical ventilation,long-term inhalation of glucocorticoids,home oxygen therapy,and procalcitonin(PCT)≥2.0 ng/mL in the occurrence group were higher than those in the non-occurrence group,and the differences were statistically significant(P<0.05).Logistic regression analysis showed that age≥70 years,combined diabetes mellitus,mechanical ventilation,long-term inhalation of glucocorticoids,home oxygen therapy,and PCT≥2.0 ng/mL were all risk factors for community-acquired pneumonia in the COPD patients(OR>1,P<0.05).Conclusions:Age≥70 years,combined diabetes mellitus,mechanical ventilation,long-term inhalation of glucocorticoids,home oxygen therapy,and PCT≥2.0 ng/mL are the risk factors for community-acquired pneumonia in the COPD patients.
万方数据
维普
